Faculty of Medicine

What's New in Research Funding

Molecular structuresPage last updated September 13, 2019

We are pleased to assist the research community in identifying potential sources of funding through the provision of information posted here:

  • All Applicants submitting through the University of Toronto MUST have submitted their application information online via the My Research Applications (MRA) portal. This is an online submission process to obtain institutional approval on research applications. Please note that you will be required to upload a copy of the application to this online submission. Please complete this step as early as possible and at least several days ahead of the deadline to insure all approvals are obtained on time. Please visit the OVPRI's MRA webpage for complete information on this process.
  • Please note, all grants requiring the Dean's signature should be brought to the Faculty of Medicine Research Office in the Medical Sciences Building, Room 2331 to the attention of Cindy Faber cindy.faber@utoronto.ca.
  • Also, our office offers a grant editing service for researchers submitting proposals to tri-council or any other funding agency. For more information, please contact dan.harney@utoronto.ca.
  • Recently received news and updates are posted below and sent via email to our LISTSERV. To join click here.

Comprehensive funding opportunities may be searched through these links:

Recently Received News and Updates

 

September 13, 2019

  • INFORMATION SESSIONS on Equity, Diversity, and Inclusion in Research and Innovation. The Division of the Vice-President, Research and Innovation, and the Centre for Research & Innovation Support are pleased to offer two information sessions for faculty members interested in learning how to promote equity, diversity, and inclusion (EDI) in research and innovation. These sessions are designed to help researchers integrate EDI principles into their research and training activities and craft research funding proposals that effectively address EDI considerations.
    • EDI in Research Teams and HQP Training: This information session will communicate best practices for the composition and management of a research team or a group of trainees. A panel of U of T researchers will share strategies to meaningfully engage under-represented groups, develop equitable team management and training practices, and create an inclusive environment. The session will also highlight resources at U of T that support EDI.
      Date: Thursday, September 26, 9am - 11am. Location: SciNet Offices, Suite 1140, MaRS West Tower, 661 University Ave., Toronto.
    • Diversity in Research Design: This information session will focus on considering sex, gender, and/or diversity in research design and the research process. Presenters will provide an overview of the concepts of sex/gender and GBA+ (gender-based analysis plus) in research, and a panel of U of T researchers from a range of disciplines will discuss how they have integrated considerations of sex, gender, and other factors into their research questions and methods.
      Date: Thursday, October 3, 9am - 11am. Location: SciNet Offices, Suite 1140, MaRS West Tower, 661 University Ave., Toronto.
       
  • Forging Research Collaborations with Japan (SEMINAR). Learn about funding opportunities for research with/in Japan with representatives from JSPS, Mitacs, and NSERC. Learn about the Centre for the study of Global Japan with the Director of CSGJ. A panel discussion on research collaboration with Japan will follow. RSVP to tak.koguchi@utoronto.ca by September 20th. 
    Date: Wednesday, October 2, 2019 from 1:30pm - 4pm, with reception to follow from 4pm - 5pm. 
    Location: University of Toronto, Hart House - Music Room, 7 Hart House Circle, Toronto.
     
  • New challenges from Innovative Solutions Canada. The Innovative Solutions Canada program provides funding to startups and small businesses to provide solutions to federal government agencies. The program facilitates the early development, testing and validation of prototypes, as well as accelerating commercialization for innovative technologies. Up to $150,000 in support to develop a proof of concept, and if approved, up to $1 million to develop a protoype. The program is open to incorporated startups and small businesses (<499 employees). Current challenges include:
    •    Machine learning to improve organ donation rates and make better matches (Closes October 18, 2019)
    •    Point of Care Diagnostics to combat Antimicrobial resistance (Closes October 18, 2019)
    •    Foot-and-mouth disease vaccine matching (Closes October 24, 2019)
    •    Data Centre Discovery Tool with Options Analysis (Closes October 24, 2019)
    •    Hybrid Ceramic Powder Processing System (Closes October 29, 2019)
    •    Stable Liposomes as Drug Carriers (Closes October 29, 2019)
     
  • Cancer Research Institute: Technology Impact Award. The program is designed to encourage collaboration between technology developers and clinical cancer immunologists in addressing the gap between technology development and clinical application of cancer immunotherapies. The ultimate aim of this program is to advance technologies that can speed up the entire field’s efforts in addressing one of the most defining challenges of our time—developing immunotherapies that are effective for all cancer patients. The most competitive applicants will address areas where technological innovation stands to benefit the field and cancer patients most, and that will ultimately lead to effective next generation personalized cancer immunotherapies. Amount: USD $200,000 over two years. Deadline for Letters of Intent: November 15, 2019. Selected applicants will be invited to submit a full research proposal, due March 15, 2020.
     
  • NIH Various Opportunities. Visit here to see the National Institutes of Health's recently released requests for applications and program announcementsFor more information on NIH application and the submission process, please visit the University's Research Funding Opportunities found here.
     
  • Crohn's and Colitis Foundation of America Inc.
    • Litwin IBD Pioneers Initiative. The program encourages novel research into the diagnosis, identification of clinically relevant subsets, treatments, and cures for inflammatory bowel diseases (IBD) and funds innovative pilot research so that scientists can test their initial ideas and generate preliminary data. Litwin IBD Pioneers supports researchers who are exploring all possible opportunities for diagnostic and therapeutic improvements, including novel, out-of-the-box ideas, and funds innovative and pioneering ideas that have a clinically relevant focus. Additionally, the program is open to investigators from other disciplines new to the IBD field, as well as countries outside the United States. There is no fixed upper or lower limit of funding, but awards are generally not funded above USD $130,000 for up to two years. Deadline for Letters of Intent: November 5, 2019.
    • Senior Research Awards. The goal of the Senior Research Award (SRA) is to provide established researchers with funds to generate findings that have an impact on the field of IBD to advance the mission of the Foundation. This impact could be evaluated by various measures, including follow-on funding from other sources, such as the National Institutes of Health (NIH), publications with high impact, and related patents or citations within patents. Total maximum award per year: USD $115,830 for up to 3 years. Deadline for Letters of Intent: November 5, 2019.
       
  • BrightFocus Foundation.
    • National Glaucoma Research (NRG): Standard Awards. Preference is made for exciting pilot projects that would not, at their present stage, be competitive for large government or industry awards. Please note that applicants to the NGR program are encouraged to apply for funding to create tools that would benefit all investigators in the field, including animal models of disease, or cell lines. Up to USD $200,000 over two years. Deadline for applications: November 8, 2019.
    • Alzheimer's Disease Research (ADR): Postdoctoral Fellowship Awards. Postdoctoral fellowship awards are intended for young researchers in their final stages of mentored training. These awards fund projects in an established laboratory that will serve as the basis for the applicant's own independent research career. Fellowships are limited to researchers within 5 years of doctoral degree conferral (or end of residency). All other applicants are encouraged to apply for a standard award. Amount: USD $200,000 over two years. Deadline for proposals: November 4, 2019.

 

September 4, 2019
 

  • Physicians' Services Inc. (PSI) Foundation. 
    • PSI Graham Farquharson Knowledge Translation Fellowship 2020. This Fellowship is intended to provide salary support for a new Ontario investigator, who has demonstrated the ability to successfully complete high impact knowledge translation research. The Fellowship’s funds, dedicated to salary support, must protect at least 50% of the Fellow’s time to conduct such research. This program offers two options for a funding timeline for salary support: A maximum $150,000 per year for two years OR a maximum of $100,000 per year for three years. The fellowship will be offered annually. Even though this program is intended to offer salary support and protect research time for the successful fellow, the fellow may allocate up to 25% of the total award to undertake a research project. Only two applications will be selected for submission and formally endorsed by the institution. Faculty of Medicine Internal Deadline: Friday, September 27 at 9am.
    • PSI Research Trainee Fellowship 2020.The primary aim of this fellowship is to provide highly qualified Medical Doctors (M.D.) with clinically applicable research training opportunities and support. A maximum of $25,000 per year for two (2) years.*PLEASE NOTE: Sponsoring Institution (departments/units) are required to co-fund 50% of the amount requested from PSI. For example, if the fellow requests $40,000 per year from PSI, then the department/unit must provide $20,000 per year. Only two applications will be selected to go forward to PSI. Faculty of Medicine Internal Deadline: Wednesday, September 25, 2019 at 9am.
    • PSI Mid-Career Clinical Research Award. The primary aim of this Award is to provide salary support for an outstanding mid-career clinician-researcher whose interests align with PSI’s funding priorities. This program offers two options for a funding timeline for salary support: A maximum of $100,000 per year for three consecutive years; OR A maximum of $75,000 per year for four consecutive years. Matching Funding: The prospective applicant must secure an institutional match to be eligible for consideration.50% matching from the sponsoring institution is required. (e.g. medical school support equivalent to $50,000 for 3 consecutive years, or $37,500 for 4 consecutive years). Only three applications will be selected to go forward to PSI. Faculty of Medicine Internal Deadline: Monday October 1, 2019 at 9am.
       
  • NSERC Discovery Grant and RTI Info Sessions. Topics will include each program's application requirements, eligibility, and changes for this year’s competitions, evaluation criteria and proposal development.  These sessions will also include guest speakers (committee member or a successful applicant) who will outline details in the application and evaluation process. *For those who are unable to attend St. George sessions in person, they have set up a Skype for Business links so that you can participate in the session remotely. Details here. The Discovery Grant and RTI Info Sessions will be held on the following dates and locations:
    • St. George Campus - Discovery Grants only. September 6, 2019 from 1pm - 3pm. Location: SS 1069-Sidney Smith Hall Speaker - Dr. Deepa Kundur RSVP – Teresa Trimboli,  RFA, Research Services; 416-978-2525, Teresa.Trimboli@utoronto.ca.
    • St. George Campus - Research Tools and Instruments (RTI) only. September 13, 2019 1p.m.- 2:30 pm. Location – VPRES McMurrich Meeting Room - 1st Floor – 107 Guest Speaker – Prof. Leslie Buck RSVP – Teresa Trimboli,  RFA, Research Services; 416-978-2525, Teresa.Trimboli@utoronto.ca 
       
  • CIHR Healthy Cities Research Training Platform (HCRTP): WEBINARS. In support of the recently launched Healthy Cities Research Training Platform (HCRTP) funding opportunity, CIHR, NSERC and SSHRC will be holding a webinar to provide more information on the scope of the training platform and the application process. 
    ENGLISH Webinar: Monday, September 23, 2019 from 1pm - 3pm EDT
    FRENCH Webinar: Thursday, September 26, 2019 from 1pm - 3pm EDT
     
  • Mental Health Research Canada (MHRC) & Institute for Advancements in Mental Health (IAM): MHRC & IAM Mental Health Innovation Prize. The Mental Health Innovation Prize is designed to advance an existing early-stage support or prototype to better the lives of young Canadians. The prize focusses on the following research challenge question: How might we reduce incidences of suicide deaths among youth and young adults living with mental illness, especially psychosis or schizophrenia, in areas where health and social services are limited? Duration: 12 months; up to 18 months in exceptional circumstances. Amount: One grant of $100,000, or two grants of $50,000. Internal Deadline for UofT applicants: September 11, 2019 at 5pm. (MRA required). Deadline for Letters of Intent: September 18, 2019.
    Call for Proposals
    Submittable Application Page

     
  • Alpha Phi Foundation: Heart to Heart Grant Program. This program aims to provide $100,000 in grant funding to support innovative research studies and educational programs that aim to inform health care professionals and women about the causes, prevention and treatment of heart disease. Deadline for applications: November 5, 2019.
     
  • Susan G. Komen: Training Researchers to Eliminate Disparities (TREND) Grants. TREND Grants are intended to establish and/or to sustain an innovative training program for graduate students, who are seeking careers dedicated to understanding and eliminating disparities in breast cancer outcomes across population groups, specifically those from diverse backgrounds affected by disparities in breast cancer outcomes including minority populations. Applicants/PIs, Co-PIs and trainees are not required to be U.S. citizens or residents. Amount: Up to USD $135,000 per year (direct costs only) for up to 3 years. Deadline for applications: October 17, 2019.
     
  • Motor Neurone Disease (MND) Association: Biomedical Research Project Grants. The MND Association supports biomedical research on Amyotrophic Lateral Sclerosis and related conditions, in all relevant disciplines. The objectives of the MND Association research funding programme are to support research aimed at understanding the causes of MND, elucidating disease mechanisms and facilitating the translation of therapeutic strategies from the laboratory to the clinic. The essential purpose of the grant is to support a single project, i.e. a piece of work designed to answer a single question or a small group of related questions. Applicants can be based outside the UK and Ireland, provided the project is unique in concept or design (i.e. no similar research is being performed in the UK) and involves a significant aspect of collaboration with a UK institute. Upper amount GBP £255,000 for up to 3 years. Deadline for applications: October 25, 2019.
     
  • National PKU Alliance:
    • NPKUA Post-Doctoral Fellowships. The NPKUA is seeking proposals that will help us meet the above strategic goals, promote and encourage young investigators into PKU-related research, to close the existing gaps in the knowledge and science of PKU, and to further support existing PKU-related projects. Both United States and international academic institutions will be considered. Amount: Up to USD $55,000 per year for two years. Deadline for proposals: November 1, 2019.
    • Research Projects. The overall funding strategy of the NPKUA is to support research that will promote advances in the treatment and management of phenylketonuria, with the long term goal of facilitating the development of a cure.  The average award is USD $40,000; however exceptional applications may be funded at a higher amount if the budget request is justified. Initial grants are awarded for one year with potential of renewal based on progress made during the first year. In addition, the Alliance supports some strategic projects on an on-going basis. Deadline for proposals: November 1, 2019.
       
  • Harry J. Lloyd Charitable Trust: Melanoma Research Grants. There are three types of grants offered: Career Development (May include salary support for promising young melanoma investigators); Basic Sciences; and Translational Research. Special consideration will be given in three areas: 1) emerging novel concepts that constitute significant innovation, 2) new investigators in the field of melanoma, and 3) prevention and early detection. Amount: Up to USD $125,000 per year. Deadline for applications: November 1, 2019.



August 9, 2019

  • Connaught Innovation Award 2019-2020. Approximately, 10-12 awards of up to $50,000 will be allocated in the 2019-20 competition to accelerate the development of promising technology and promote commercialization and/or knowledge transfer.  Projects must be at or above Technology Readiness Level (TRL) 4 as defined by Science and Economic Development Canada (SEDC).  Information regarding SEDC TRL Scale can be found here.  Successful projects will have strong socio-economic and/or commercial potential, and will strive to have a positive impact on society. Deadline for Notices of Intent: September 10, 2019; Full application deadline: October 15, 2019. Projects must be based on inventions or research discoveries that are already disclosed to the University as of August 27, 2019.
     
  • SSHRC Insight Grant Information Sessions. UofT Research Services will present SSHRC IG info sessions on all three campuses, which will include presentations from recent SSHRC evaluation committee members and Research Services staff. Details on each can be found on the University's Insight Grant funding opportunity webpage.
    UT Mississauga: Tuesday, September 10, 2019 from 10am-11am
    UT Scarborough: Wednesday September 11, 2019 from 10am-11am
    UT St. George: Friday, September 13, 2019.
     
  • Banting and Best Diabetes Centre (BBDC): Sun Life Financial New Investigator Award 2020-2022, and Reuben & Helene Dennis Scholar in Diabetes Research 2020-2022. These awards are intended to support new clinician-scientists and basic scientists in the early stages of their careers. One Sun Life Financial New Investigator Award and one Reuben & Helene Dennis Scholar award will be made available for this competition. Funds may be used for diabetes research support and/or the salary of a clinician-scientist conducting diabetes research. Deadline for applications: October 22, 2019 at 4pm. 
     
  • Heart & Stroke Foundation:
    • Grants In Aid (GIA): Research is supported across four health research themes: Basic Biomedical; Clinical; Health Services/Systems; and Social, Cultural, Environmental and Population Health. Amount: Up to $100,000 for up to 3 years. Deadline for applications: August 29, 2019.
    • Personnel Awards: Includes the National New Investigator Program and the Seed/Catalyst Grant Program. Deadline for applications: September 5, 2019.
       
  • NSERC Research Tools and Instruments (WEBINARS). In order to be better prepared for NSERC webinars, please familiarize yourself with the following documents:
    •    RTI program description which includes the Peer Review Manual (which will be updated shortly) and Frequently Asked Questions.
    •    Instructions for Completing an RTI Application..
    English: August 13th and August 20th from 1pm-3pm (ET)
    French: August 15th and August 22, 2019 from Ipm-3pm (ET)
     
  • Canadian Allergy, Asthma, and Immunology Foundation (CAAIF): Research Grant for New Investigators. The objective of the Research Grant is to support fellows or new investigators who are studying or
    practicing allergy and clinical immunology. The research project can be in progress and must have clinical relevance. Amount: Up to $10,000. Deadline for applications: September 13, 2019.
     
  • Multiple Sclerosis Society of Canada: Discovery Research (Operating) Grants. This Program is intended to support various research projects aligned with the MS Society of Canada’s new strategic plan. The strategic plan outlines four key impact areas: Treatment and Care; Enhance Wellbeing; Understand and Halt Disease Progression; and Prevent MS. Based on the nature of the research, applicants can apply to one of the following two streams: Biomedical Discovery Research (Operating) Grant; or Clinical and Population Health Discovery Research (Operating) Grant. Amount: $50,000 for 1 or 2 years. Deadline for applications: October 1, 2019.
     
  • Canadian Cancer Society: Grants.
    • Innovation Grants. Applications are encouraged from across all areas and disciplines of cancer research, as well as from investigators in other disciplines , whose ideas are relevant to the field of cancer. Amount: Up to $200,000 for up to 2 years. Deadline for applications: October 15, 2019.
    • Innovation to Impact (i2I) Grants. The i2I Grant was designed as the next stage in the funding pipeline for Innovation and Canadian Breast Cancer Foundation (CBCF) Grants, that have completed their original aims
      and have demonstrated productivity. Only investigators with a funded Innovation Grant (including Prevention Innovation Grants )/CBCF Grant with a project end date between January 1, 2017 and October 31, 2020 are eligible for this program. Amount: Up to $150,000 per year for up to 3 years. Deadline for applications: October 15, 2019.
       
  • Ontario Molecular Pathology Research Network (OMPRN): 2019 Cancer Pathology Translational Research Grants (CPTRG) Stream1. Projects must be likely to advance the field of cancer diagnostic, prognostic or predictive testing. Collaborations between Ontario institutions, including the trans-institutional use of core resources, are encouraged as is leveraging of existing collaborative clinical trials networks. It is expected that most proposals will make use of primary human cancer samples. Amount: Up to $35,000 for one year. Deadline for applications: October 28, 2019.
     
  • Canadian Orthopaedic Foundation: Canadian Orthopaedic Research Legacy (CORL) Grant. The objective of the CORL Grant is to support new techniques and treatments in novel, short-term research projects which could include: a new investigator, possibly paired with an experienced team; an experienced investigator seeking funding for a pilot project. Amount: $20,000 for 1-2 years. Deadline for applications: October 31, 2019.
     
  • The Michael J. Fox Foundation: Therapeutic Pipeline Program. The objective of this program is to support the development of Parkinson’s disease therapeutics with potential for fundamentally altering disease course and/or significantly improving treatment, or management of symptoms, beyond current standards of care. Programs developing novel approaches, as well as approved or clinically safe repurposed or repositioned therapies from other disease indications, are appropriate. Amount: Up to USD $500,000 over 1-2 years. 
    WEBINAR: September 12, 2019 from 12:00 - 1:00pm ET.
    Deadline for pre-proposals: September 24, 2019.
     
  • Alex's Lemonade Stand Foundation: Crazy 8 Initiative Award Program. The Crazy 8 Initiative Award will fund research into innovative and rigorous approaches that directly address the most intractable issues in pediatric cancer research today. This award is designed to coalesce cross-disciplinary cores of scientists working collaboratively in order to accelerate the pace of new cure discovery. See the RFA for details. Amount: potential for impact. Depending on the type of project and the size of the team, the requested budget should be in the range of USD $1-5 million over 4 years. Deadline for Letters of Intent: October 1, 2019.
     
  • National Ataxia Foundation: Research Grants.
    • The Young Investigator Award was created to encourage young clinical and scientific investigators to pursue a career in the field of ataxia research. Deadline for Letters of Intent: October 1, 2019.
    • Seed Money Research Grants are for new and innovative studies that are relevant to the cause, pathogenesis or treatment of the hereditary or sporadic ataxias. Deadline for Letters of Intent: September 16, 2019.
    • Pioneer SCA and SCA3/MJD Translational Research Award is for research projects that will facilitate the development of treatments for the Spinocerebellar Ataxias. Deadline for Letters of Intent: October 15, 2019.
    • Post-doctoral Fellowship Awards are to serve as a bridge from post-doctoral positions to junior faculty positions. Deadline for Letters of Intent: October 15, 2019.
       
  • American Fibromyalgia Syndrome Association (AFSA): Research Grants. Visit their website for priority areas of funding. Amount: Up to USD $50,000 for one year. Deadline for Letters of Intent: Continuous.

 

July 18, 2019
 

  • New Frontiers in Research Fund (NFRF) - Exploration 2019 - UofT Tips and Checklist now available. All competition documents are available on the NFRF website and the Convergence Portal is open.
    The University of Toronto’s Research Services Office has now prepared an NOI Tips and Checklist document, available on the UofT funding opportunity listing, that applicants may use as an additional resource to those available from NFRF. If your primary affiliation is at one of the affiliated hospitals you should apply through that institution as your Administering Organization. You will not be able to change your Administering Organization from the NOI to the LOI (and then to the Full Application) stage so it is important to apply with the correct affiliation now. It is the responsibility of the Nominated Principal Investigator to ensure that each team member is eligible and that the team’s composition meets all of the program’s eligibility guidelines. 
    UoT internal deadline: August 1, 2019.
    WEBINAR SLIDE PRESENTATIONS: English; French

     
  • University of Toronto - July 29 Launch: New online submission process for Material Transfer Agreements, Confidential Disclosure Agreements, and other non-funded research agreements. On Monday, July 29th, 2019, the process for initiating the following types of non-funded research agreements will change:
    •    Material Transfer Agreement (MTA)
    •    Confidential Disclosure Agreement (CDA)
    •    Data Transfer Agreement (DTA)
    •    Research Memorandum of Understanding (MOU)
    •    Research Equipment Loan Agreement
    •    Visiting Scientist IP Agreement
    •    Non-Funded Research Collaboration Agreement
    The Division of the Vice President, Research & Innovation (VPRI) in partnership with the Office of the Chief Information Officer (CIO) are expanding the My Research Applications (MRA) service to allow researchers to electronically submit requests for non-funded research agreements via the web portal to the Innovations & Partnerships Office (IPO) for institutional approvals and processing. Visit here to see the benefits of this expanded service, resources, contact information and other information.
     
  • CIHR Project Grants: Fall 2019 Competition - Learning for Applicants and upcoming webinars. CIHR just launched the Project Grant: Fall 2019 Competition and related Priority Announcements. The Learning for Applicants page has been updated with materials to support applicants through the Registration and Application stages of the competition. Specifically, these learning materials include:
    •    Modules: Project Grant modules are listed on the Learning for Applicants page and provide an overview of the competition as well as a detailed tour of the application process, including requirements such as completing the Equity and Diversity Questionnaire
    •    Webinars: Spaces are still available in the Project Grant: Fall 2019 Question and Answer webinars, which will run until August 28th. All attendees are asked to review the presentation, reference materials and applicant learning modules in advance of the webinar to ensure that everyone’s experience is as productive as possible.
     
  • The Kidney Foundation of Canada: Kidney Health Research Grants (formerly Biomedical Research Grants). The Kidney Foundation of Canada is pleased to announce that the value of this grant has increased to $120,000 over two years with a maximum of $60,000 per year. The Kidney Health Research Grant competition has moved to an on-line application system. All forms, policies and procedures can be found on the proposalCENTRAL website. Deadline for Letters of Intent: September 1, 2019; Full applications due: October 1, 2019.
     
  • Cancer Research Institute (CRI): Irvington Postdoctoral Fellowship Program. This program supports qualified young scientists at leading universities and research centers around the world who wish to receive training in fundamental immunology or cancer immunology. Fellowships provide a stipend of $55,000 for the first year, $57,000 for the second year, and $59,000 for the third year. Sponsor deadline: October 1, 2019.
     
  • NIH Various Opportunities. Visit here to see the National Institutes of Health's recently released requests for applications and program announcements. For more information on NIH application and the submission process, please visit the University's Research Funding Opportunities found here.
     
  • National MS Society.
    • Pilot Research Grants. The grants are awarded for one year for research conducted by scientists and clinicians that focus on unique or novel ideas with the potential to open significant new areas of research on multiple sclerosis. The maximum budget is USD $50,000 in direct costs. Deadline for applications: September 11, 2019.
    • Research GrantsThe grants are awarded to multi-year research conducted by scientists and clinicians involving basic, clinical and rehabilitation research for a period of 1 to 5 years. Deadline for applications: August 7, 2019.
       
  • Simons Foundation Autism Research Initiative (SFARI): Winter 2020 Pilot Grants. SFARI is now accepting applications that address areas relevant to improving the scientific understanding, diagnosis and treatment of autism spectrum disorders. These areas include genetics and other factors contributing to risk; molecular and cellular mechanisms; synaptic and circuit physiology; sensory perception; cognition; behaviour; and clinical and translational studies. The Pilot Award supports innovative, high-impact, proposals requesting support for small-scale projects or early-stage experiments that build on preliminary data.  The maximum budget is USD $300,000 (including 20% indirect costs) for up to 2 years. Deadline for submissions: September 13, 2019.
     
  • Meso Foundation: Grants for Mesothelioma Research. The Meso Foundation (formerly known as MARF) is a nonprofit dedicated to ending the suffering caused by mesothelioma. They are the international collaboration of patients and families, physicians, advocates, and researchers dedicated to eradicating the life-ending and vicious effects of mesothelioma. Amount: Up to USD $50,000 per year for up to two years. Deadline for Letters of Intent: August 26, 2019; Full applications due: January 8, 2020.
     
  • American Foundation for Suicide Prevention (AFSP): Linked Standard Research Innovation Grants. All AFSP research grants are designed to support research on suicide from a variety of disciplines including psychiatry, medicine, psychology, genetics, epidemiology, neurobiology, sociology, nursing, health services administration, social work, and many others. Grants are not intended to support the development or implementation of prevention programs, educational programs, treatments, or other interventions that do not have a significant research component. Amount: Up to USD $300,000 for up to two years. Deadline for Letters of Intent: September 15, 2019; Full applications due: November 15, 2019.
     
  • Scleroderma Foundation: Established Investigator Award. The Scleroderma Foundation seeks applications from promising established investigators both inside and outside the field of scleroderma research who wish to propose pilot studies to obtain preliminary data dealing with a highly innovative and/or highly relevant theme related to the disease. This grant will support pilot research that is likely to lead to more substantial unlimited research project grants from federal or non-federal sources. Amount: Up to USD $150,000 for up to two years. Deadline for applications: September 16, 2019.

July 4, 2019
 

  • New Frontiers in Research Fund (NFRF) - Exploration 2019. All competition documents are available on the NFRF website and the Convergence Portal is open. The objective of this competition is to generate opportunities for researchers at all career stages to conduct high-risk, high-reward and interdisciplinary research not available through funding opportunities currently offered by the three agencies. It seeks to inspire highly innovative projects that defy current research paradigms, propose a unique scientific direction, bring disciplines together beyond the traditional disciplinary approaches, and/or use different perspectives to solve existing problems. Amount: Up to $125,000 per year over 1 or 2 years (includes $25,000/year indirect costs). Projects must include elements from at least two different disciplines (as defined by a group-level classification based on the Canadian Research and Development Classification). Projects must meaningfully engage members of underrepresented groups within the research team, and are expected to integrate sex and gender in their research designs, when appropriate. For full details on project requirements, please see the funding opportunity description. NOI deadline: August 7, 2019; LOI deadline: September 4, 2019; Application deadline: December 10, 2019. Information of UofT applicants can be found here.

    NFRF- Explorations 2019 NOI Webinars: NFRF will be hosting webinars for applicants and research administrators at each stage.  There is a limit of 1000 attendees per webinar so participants are encouraged to join webinars as a group.  Links to the webinar will publicly available approximately one hour prior to the start time. Webinars will be recorded and presentations available following the session.
    English - July 9 from 1pm-3pm or July 17 from 10am-12pm
    French - July 10 from 10am-12pm or July 15 from 1pm-3pm
     
  • NSERC Chairs for Women in Science and Engineering Program. The call is open to the Ontario and Prairies regions. The aim of this program is to increase the participation and retention of women in science and engineering, while also providing role modes for women that are in, and considering, careers in these fields. The CWSE Program is regional—with one Chair for each of the Atlantic, Quebec, Ontario, Prairies, and British Columbia/Yukon regions. Details about this program and how to apply can be found here. Internal deadline for nominations: September 4, 2019; Sponsor deadline: October 8, 2019.
     
  • Stem Cell Network: Research Funding Programs. Deadline for full applications for all programs: August 8, 2019.
    • Translation and Society Program supports ethical, legal and social implications projects that focus on impediments in the translation of innovative stem cell research. Amount: Up to $75,000 over 25 months.
    • Fueling Biotechnology Partnerships Program supports academic partnerships with emerging Canadian regenerative medicine biotech companies, who are working to drive an innovative stem cell based technology or therapy into the clinic or market. Amount: Up to $500,000 over 25 years.
    • The Accelerating Clinical Translation Program supports multi-disciplinary research projects focused on stem cell-related technologies or cell therapies expected to reach clinical trials activity within five years. This
      program will also support translational research activities (including Ethical Legal and Social Implications (ELSI) questions) associated with an ongoing clinical trial that will enable the trials next phase of activity. Projects principally focused on basic research are not eligible for funding. Amount: Up to $600,000 over 25 months. 
    • The Advancing Clinical Trials Program supports projects that focus on novel cellular or stem cell-related therapeutic approaches to tissue repair and regeneration for specific diseases. Eligible clinical trials must be testing Canadian innovations at the Phase I or II stage, have received both Research Ethics Board (REB) and Clinical Trials Approval (CTA) from Health Canada, and are not duplicative of other research taking place globally. Amount: Up to $1,000,000 over 25 months.
  •  
  • Cancer Research Institute (CRI): Clinic and Laboratory Integration Program (CLIP). CRI offers CLIP grants to qualified scientists who are working to explore clinically relevant questions aimed at improving the effectiveness of cancer immunotherapies. The grant will support basic, pre-clinical, and translational research that will provide information that can be directly applied to optimizing cancer immunotherapy in the clinic. In partnership with the Chordoma Foundation, CRI has secured designated funding that will provide for additional CLIP grants focused on topics related to accelerating the development of effective treatments and ultimately a cure for chordoma. Amount: $200,000 over two years. Deadline for LOIs: November 1, 2019; Invited application deadline: February 15, 2020.
     
  • Burroughs Wellcome fund: Investigators in the Pathogenesis of Infectious Disease. The objective of this funding opportunity is to support accomplished investigators, at the assistant professor level, to study pathogenesis with a focus on 1) the interplay between human and microbial biology, and 2) the fundamentals that affect the outcomes of these encounters: how colonization, infection, commensalism and other relationships play out at levels ranging from molecular interactions to systemic ones. Amount: Up to USD $500,000 over 5 years. Deadline for pre-proposals: July 15, 2019.
     
  • Leukemia & Lymphoma Society (LLS): Specialized Center of Research (SCOR) Program. The SCOR grant program is intended to bring together established investigators from one or several institutions to develop a focused research program, foster new interactions and cooperation, and enhance interdisciplinary research among the participants. The overall goal of this mechanism is to enhance the development of innovative strategies for the treatment, diagnosis or prevention of hematological malignancies. Strategies that move discoveries from the bench to the clinic are of high importance as are integrated translational projects. A major focus is translatability to the clinic within the time frame of the SCOR, or shortly after the grant term ends. Amount: Up to $5,000,000 over five years including indirect costs. Deadline for Letters of Intent: August 31, 2019.
     
  • Susan G. Komen: Career Catalyst Research Grants. The objective of the Career Catalyst Research Grant is to 1) support early career breast cancer researchers, 2) bridge the funding gap faced by faculty as they start their careers in breast cancer research, and 3) prepare early researchers to compete for future independent funding. The grant provides support for hypothesis-driven research projects. The topic area for the FY20 Career Catalyst Research Award is Redefining Metastatic Breast Cancer through Liquid Biopsy.  Amount: USD $150,000 per year for three years including indirect costs. Registration deadline: July 10, 2019: Deadline for Letters of Intent: July 29, 2019.
     
  • National Eczema Association: Research Grants. Deadline for applications: August 30 at 5pm PDT.
    • Engagement Research Grant: Small research grants for emerging investigators intended to explore a new research concept, pilot a new experiment or undertake a novel or secondary data analysis. Amount: Up to USD $5,000 for each project.
    • Catalyst Research Grant: Designed to support talented early-career scientists on the path toward becoming the next generation of eczema thought leaders by supporting hypothesis-driven research projects. Amount: Up to USD $50,000 for each project.
    • Eczema Champion Research Grant: Encourages proven researchers to continue research on emerging or ongoing challenges in eczema or bring their expertise to the field of eczema. Amount: Up to USD $100,000 for each project.
       
  • National Multiple Sclerosis Society: Pilot Research Grants. The objective of these grants is to provide funds for limited, short term support of research in areas where preliminary data are scant or nonexistent. The program is designed to support new, unique or novel ideas with the potential to open significant new areas of research on multiple sclerosis. Amount: Up to USD $50,000 for one year in direct costs. Deadline for pre-applications: September 9, 2019.

June 28, 2019
 

  • University of Toronto: 2020 President's Impact Awards. These annual awards celebrate and honour faculty members whose research has led to significant impact beyond academia. President’s Impact Award winners receive a monetary award of $10,000 per year for five years to be used toward their research, and are also designated by the University as members of the President’s Impact Academy for a minimum of five years. Nominations should be led by a Chair, Academic Director, Vice- or Associate Dean Research, or Vice-Principal Research as appropriate, and must be endorsed by the nominee’s academic division. The deadline for nominations is Thursday, October 31, 2019. Please check with divisional awards offices for earlier internal deadlines. Nominees whose research impact is related to public policy may be simultaneously nominated for the Carolyn Tuohy Impact on Public Policy Award, a separate award that is presented annually under the banner of the U of T Awards of Excellence. Visit here for eligibility and other criteria.
     
  • CIHR Pre-Announcement: Methamphetamine and Related Psychostimulant Use Operating Grants. The use of methamphetamines and other psychostimulants is increasing but there is a relative lack of high-quality data on the scale of the issue, and its impacts on healthcare and the health service system. This funding opportunity is designed to lay the groundwork for successful interventions at all levels – including treatment, harm reduction, and at the levels of health service systems and health care policies. Amount: Up to $100,000 over one years. Launch: July 2019; Registration deadline: August 2019; Deadline: September 2019.
     
  • New Frontiers Research Fund - Transformation: Pre-Release Framework and ConsultationThe Canada Research Coordinating Committee (CRCC) released the Transformation Stream program framework, and invites the community to provide feedback on the framework in advance of an anticipated program launch in October 2019. The Transformation stream is designed to support large-scale, Canadian-led interdisciplinary research projects that address a major challenge with the potential to realize real and lasting change (high reward). The challenge may be fundamental, leading to a scientific breakthrough, or applied, with a social, economic, environmental or health impact. Projects are expected to be world-leading, drawing on global research expertise, where relevant. Up to 6 awards of $24M ($4M per year), including direct costs, may be awarded. Stakeholders are invited to provide feedback, comments, suggestions and questions on the Framework to CRCC by August 1, 2019. The University of Toronto will be coordinating an institutional response.  You are welcome to send us your comments for inclusion in the institutional response, please email NFRF.Transformation@utoronto.ca before July 29, 2019.  Alternatively, you may send feedback directly to the CRCC by email at NFRF-FNFR@chairs-chaires.gc.ca and kindly copy NFRF.Transformation@utoronto.ca
     
  • Canada-UK Artificial Intelligence Initiative. This initiative is an interdisciplinary joint call aimed at building competitive, resilient and healthy economies and societies through responsible AI. The call aims to support innovative and cutting-edge interdisciplinary AI research that encourages the exploration of new interdisciplinary research methodologies, approaches and tools that cuts across at least two of the following research domains:
    •    social sciences and humanities;
    •    health and biomedical sciences; and 
    •    natural sciences and engineering (including computational and/or mathematical sciences).
    The total amount available for this funding opportunity is about C$14 million (£8.2 million), enough to fund up to approximately 10 projects. Canadian applicants are only eligible to receive funding from the Canadian agencies and UK applicants are only eligible to receive funding from UKRI. Each grant will require a Principal Investigator (PI) based in Canada and a PI based in the UK from different research domains, who will jointly develop one application and equally share leadership and project management for each project. Further details here. WEBINAR for potential applicants: July 17, 2019.
    Compulsory Intention to Submit: August 19, 2019.
     
  • Biocodex Microbiota Foundation - Microbiome in human health and diseases. Biocodex Microbiota Foundation is calling on inspired researchers at Canadian institutions in the microbiome field to submit proposals for funding their projects. This Canadian grant of 25,000 €.will be awarded to an early career investigator studying a 1 - 2 year long research project within the topic of microbiome in human health and diseases. The grant is intended as a seeding or bridging grant, to help investigators become independent or advance in the progression of their career. Holders of CIHR Foundation grants or total funding exceeding 200k per year may not apply. Deadline for applications: October 31, 2019.
     
  • Immunodeficiency Canada: Chaim Roifman Scholar Award for Senior Investigators. Each fall, Immunodeficiency Canada requests proposals focused on research in primary immune deficiency (PI). Research objectives should address one or more of the unique needs of patients with primary immunodeficiency: 
    - Study the clinical, cellular and molecular characteristics of genetically determined immunodeficiency diseases 
    - Discover improved diagnostic tools for PI 
    - Advance novel therapeutic approaches for PI 
    - Advance education of patients and medical professionals
    Amount: Up to $60,000. Deadline for Letters of Intent: September 27, 2019; Application deadline: November 29, 2019.
     
  • American Association for Cancer Research (AACR): Stand Up to Cancer Gastric Cancer Interception Research Team.  This Team Grant represents a new, focused effort to implement advances in gastric cancer interception and prevention research as rapidly as possible through the creation of a collaborative, translational, cancer "Research Team". The most talented and promising researchers across institutions will be assembled into a Research Team, forming an optimal configuration of expertise needed to solve key problems in gastric cancer interception and prevention research. This Research Team will span multiple disciplines within and beyond the gastric oncology community, ideally including investigators with expertise outside the biological sciences, and utilize new tools to answer research questions in a coordinated way. One grant of up to USD $3 million will be awarded. Deadline for Expressions of Interest: July 30, 2019; Application deadline: August 20, 2019. 
     
  • American Association for Cancer Research (AACR): AACR-Johnson & Johnson Lung Cancer Innovation Science Grants. These grants represent a joint effort to address the need for promoting and supporting collaborative cancer research in areas that include digital therapeutics and smoking cessation biomarkers/behavioral phenotyping, to bolster our understanding of how lung cancer can be successfully intercepted. This project must be implemented by a multi-institutional team, composed of Principal Investigators from at least two, but no more than three, different institutions and include a clinical component with an endpoint relevant to improving the detection or treatment of lung cancer. Amount: Up to USD $1 million over three years. Deadline for applications: July 19, 2019.
     
  • Leukemia & Lymphoma Society (LLS): Translational Research Program (TRP). Applications are sought proposing novel approaches to the prevention, diagnosis or treatment of hematological malignancies and related pre-malignant conditions. Proposals should be based on molecular, cellular or integrated systems findings and be conceptually innovative. The application should have a clear plan for the clinical translation of the studies proposed and the results expected. This feature will be an important consideration of the review process. Amount: USD $650,000 over two years. Deadline for Letters of Intent: August 31, 2019; Application deadline: October 31, 2019.
     
  • Benign Essential Blepharospasm Research Foundation, Inc. (BEBRF): Request for Blepharospasm/Meige Research ProposalsFunds are available for support of research directly related to the cause of, treatment for, and complications derived from treatments for benign essential blepharospasm or Meige's Syndrome, both forms of cranial dystonia. Proposals for improvement of existing treatments and for new treatments (such as medical marijuana and neuroplasticity training for blepharospasm) are welcome. Novel therapies for apraxia of eyelid opening, dry eye, and photophobia will also be considered for funding. Amount: Up to USD $100,000 for one year. Deadline for applications: August 31, 2019.
     
  • American Gastroenterological Association (AGA): Rome Foundation Functional GI and Motility Disorders Pilot Research Award. The objective of this AGA Research Foundation award is to provide investigators funds to help establish their research careers or support pilot projects that represent new research directions. The intent of the award is to stimulate research in the areas of functional GI and motility disorders by providing time for investigators to obtain new data that can ultimately lead to subsequent grant applications for more substantial funding and duration. Two, one year, USD $30,000 research grants are offered. Deadline for applications: September 4, 2019.
     
  • Alzheimer's Research UK (ARUK): Dementia Consortium - Target validation and drug discovery projects funding. Projects should provide evidence linking the target to human disease and a strong rationale for target modulation having a therapeutic effect. Target validation studies consisting of preclinical research that aims to give confidence in the relevance of a novel target to a disease are supported. Approaches can cover all aspects of dementia therapy, from treating the underlying pathology to improving cognition and other mental symptoms. Targets must be early stage, but should have some data to support their role in disease. Projects are collaborative in nature, with involvement from the consortium members in devising the final project plan. Upper amount: GBP £500,000. Registration deadline: Continuous. 
     
  • Action for A-T: Research Grants. A wide range of research applications will be considered for funding but Action for A-T has a particular interest in cancer and the respiratory manifestations in A-T. Applications are considered for high quality biological science or translational research projects that may lead to treatments and cures for A-T from applicants in the UK and worldwide. UK based projects will be prioritised for funding. Action for A-T also retains flexible funding so that it can jointly fund research with others during the year and is able to respond quickly to important emerging information and techniques. Amount: Up to GBP £250,000 lasting up to three years. Deadline for applications: September 23, 2019.

 

June 19, 2019
 

  • Cystic Fibrosis Canada: 2019 Fall Research Competition.  Cystic Fibrosis Canada’s fall research competition is designed to support leading research into the understanding, management and treatment of, and cure for, cystic fibrosis (CF). All applications must address Cystic Fibrosis Canada’s Core Principles of funding the best science that has the highest probability of making an impact for CF patients. Both Basic Science grants and Clinical Research grants are available. Amount. Up to $100,000 per year for 3 years. Budgets above this amount will be accepted in there is a funding partner. Deadline for Notices of Intent: July 31, 2019 at 5pm. Final application deadline: October 1, 2019.
     
  • NIH Various Opportunities. Visit here to see the National Institutes of Health's recently released requests for applications and program announcementsFor more information on NIH application and the submission process, please visit the University's Research Funding Opportunities found here.
     
  • American Foundation for Suicide Prevention: Focus Grants - Blue Sky Research Grant. Supports an innovative, impactful study in an area of suicide research that will achieve significant goals. The goal of this grant is creating innovative projects in new areas of investigation with potentially high impact for the understanding and prevention of suicide. Open to all fields of inquiry. Amount: Up to USD $500,000 per year for up to three years. Deadline for Letters of Intent: August 1, 2019; Application deadline: December 7, 2019.
     
  • Boston University: CARB-X. CARB-X is investing up to $550 million in antibacterial R&D between 2016-2021. CARB-X welcomes applications from around the world for funding and support for the early development of antibiotics, diagnostics, vaccines and other products to combat the most serious drug-resistant bacteria. There are four separate CARB-X Funding Rounds in 2019:
    • Vaccines and Biotherapeutics: The scope of Round 2 is restricted to vaccines, therapeutic and preventative antibodies/fragments, and other large molecule biotherapeutic approaches. Deadline for EOIs: July 15, 2019.
    • Diagnostics: The scope of Round 3 is restricted to diagnostics that will rapidly identify either the bacterial species or antibiotic susceptibility, or both. Deadline EOIs: August 19, 2019.
    • Direct-acting small molecule antibiotics: The scope of Round 4 is restricted to new classes of antibiotics and/or new targets for therapeutics. Deadline for EOIs: November 19, 2019.
    • Non-traditional approaches: The scope of Round 2 is restricted to non-traditional approaches - alternatives to antibiotics - including, for example, indirect-acting small molecule therapeutics, direct acting or indirect-acting large molecules, microbiome, phage, nucleic acid/antisense, and drug conjugates. Anticpated deadline for EOIs: June 10, 2020.
       
  • Global Lyme Alliance (GLA): Research Grant Award Program. GLA has awarded more than $10 million in grants to scientists at more than 40 academic institutions to study Lyme and other tick-borne diseases. Proposals are expected to be of high scientific quality from scientists and clinicians who use evidence-based, data-driven research to drive knowledge forward. Research priorities include Lyme Disease and Babesiosis. Projects are expected to be completed in one to two years. Deadline for Letters of Intent: July 22, 2019.
     
  • Wings for Life (WFL) Spinal Cord Research Foundation: Project Research Grant. Research projects may address all aspects of spinal cord lesions; nerve regeneration; trophic support of lesioned neurons; functional changes induced by lesions; and preferentially in mammalian models. Proposals should have a view to translation from the laboratory to the clinical setting, and have the potential to provide real benefits to human patients. Amount: Up to EUR €100,000 per year all inclusive. Deadline for executive summary: September 2, 2019; Application deadline: November 2, 2019. 
     
  • Wellcome Trust: Impact of vaccines on antimicrobial resistance (NEW). This supports researchers investigating the impact of vaccines on antibiotic use and antimicrobial resistance with the aim of informing vaccine decision-makers around the world and tackling antimicrobial resistance. Projects must aim to analyse data on antimicrobial resistance or antibiotic use in the context of a vaccine study. They may analyse existing data or collect and analyse new data from an ongoing or planned vaccine study. Data may include antibiotic use, drug-resistant infections, antibiotic prescribing behaviour and antibiotic seeking behaviour. Amount: Up to GBP £750,000 and the duration of the programme is flexible and dependent on the level of funding. Deadline for preliminary proposals: September 6, 2019; Full proposals due September 12, 2019.
     
  • Mizutani Foundation for Glycoscience: Research Grants. The objective of the Foundation is to promote world-wide progress in glycoscience. In accordance with this objective, the Foundation provides research grants to outstanding proposals for basic and applied studies on glycoconjugate in the fields of organic chemistry, biochemistry, biophysics, molecular biology, cellular biology and medical sciences. Amount: Up to JPY ¥7,000,000 (approximately USD $58,000). Deadline for applications: September 1, 2019. 

June 13, 2019
 

  • Entrepreneurship for Cardiovascular Health Opportunities (ECHO) – Call for Applications The Translational Biology & Engineering Program (TBEP), at the University of Toronto and the Ted Rogers Centre for Heart Research, in partnership with the Health Innovation Hub (H2i) is pleased to announce a call for applications for the 2019-2020 Entrepreneurship for Cardiovascular Health Opportunities (ECHO) program.
     ECHO is a specialized experiential training program with the main objectives to:
    1.    Provide entrepreneurship training, mentorship, networking and funding opportunities for early ventures in the cardiovascular health sector.
    2.    Aid in transferring research innovations and intellectual property from academic and hospital institutions into the economy.
    3.    Create more start-ups in cardiovascular health sector.
    Any Canadian-based student, researcher and/or entrepreneur developing advanced cardiovascular technologies and innovations is eligible to apply. For full program information and enrolment instructions, please visit the ECHO program page. Deadline for submissions: August 1, 2019.
     
  • 2019 NSERC Discovery Grant NOI Information Session. Hosted by UofT. Topics covered in the session include the Notice of Intent, program requirements, eligibility requirements, changes for this year’s competition (Research Portal and Canadian Common CV), evaluation criteria and proposal development. Guest speaker: Professor Christopher Yip, Dean, Faculty of Applied Science & Engineering. For details on the submission and approval process, including internal deadlines, required signatures and information sessions, please see the Research Services webpage, as well as the NSERC Discovery Grants webpage. For those who are unable to attend this session in person, they have set up a Skype for Business link so that you can participate in the session remotely. Details here.
    DATE: July 9, 2019 from 1pm - 3pm
    LOCATION: Bahen Centre, BA 1200, 40 St. George St. Please RSVP to Teresa.Trimboli@utoronto.ca.
     
  • The Ministry of Economic Development, Job Creation and Trade (MEDJCT): Early Researcher Award (ERA) - Round 15. The ERA program helps promising, recently-appointed Ontario researchers build their research teams of undergraduates, graduate students, post-doctoral fellows, research assistants, associates, and technicians. The ERA program will provide funding up to $100,000 for each award (plus $40,000 for indirect costs), and must be matched by an additional $50,000 (generally from the division/department and/or a partner organization). Further details on the program including program guidelines and the application form can be found on the research funding opportunity page
    INFORMATION SESSION: July 25 from 10am - 12pm
    LOCATION: Bahen Centre, BA 1200, 40 St. George St. Please RSVP to renee.leroux@utoronto.ca. Please note that attendance of this session is limited to PIs and their support staff who will be submitting their applications through UofT.
     
  • SEEDing Innovation: First Annual XSeed and EMHSeed Poster Session. This event is an excellent opportunity to learn about the broad range of collaborative research projects funded by our seed funding programs and to identify potential future collaborations. Attendance is open to all faculty members. For planning purposes, RSVP to vdr@ecf.utoronto.ca by June 21. In addition, if you do not have a XSeed or EMHSeed project but plan on applying to the upcoming XSeed or EMHSeed competitions, we encourage you to consider presenting a poster at this event. 
    Date: Thursday, June 27, 2019 from 1pm - 3pm
    Location: Myhal Centre for Entrepreneurship & Innovation in Engineering5th Floor Atrium (MY532), 55 St. George Street
     

  • Brain Tumour Charity. These awards are open to international researchers but all proposals must demonstrate how they can benefit patients in the UK health system. Deadline proposals: September 2, 2019.
    • Clinical Biomarkers support the identification, validation, and implementation of clinical biomarkers that bring us closer to an early and accurate diagnosis, and/or inform the management of brain tumours. These grants are available for up to £100,000 per year for up to five years.
    • Quality of Life Awards provide funding to increase understanding and minimise the impact of brain tumours on those affected. Funding is up to £300,000 per project for up to three years. 
    • Expanding Theories Awards support pilot studies that explore and develop novel concepts that may eventually lead to significant improvements in clinical outcomes, including quality of life, for people with brain tumours. Applications including a UK collaborator will be looked on favourably. Funding of up to £60,000 per year, for up to two years can be requested.

June 6, 2019
 

  • REMINDER! CIHR's new Strategic Plan: Invitation for public engagement. CIHR is inviting the health research community to visit https://letstalk-cihr.ca/ its new online engagement platform to take a survey, join the discussion forum, or leave a question with respect to its new strategic plan. The online survey will be open until June 28, 2019.
     
  • NSERC: Idea to Innovation (I2I) Program - Commercialization Grants. The purpose of this program is to accelerate pre-competitive technologies for transfer to a Canadian company. Successful applicants receive awards of up to $125,000 for each phase of their commercialization project, with additional funding available as the project progresses. All projects must be based on inventions disclosed and assigned to the University, and should be managed in conjunction with the Innovations & Partnerships Office (IPO) – the Innovations team in particular can assist with development of the Commercialization Plan, and can also assist in determining the appropriate Phase for your project. UofT internal deadline: Monday, June 17, 2019 (upload and submit the application through the university's My Research Application (MRA) System); Sponsor deadline: June 25, 2019. Questions may be directed to innovations.partnerships@utoronto.ca or visit NSERC's website.
     
  • The Ministry of Economic Development, Job Creation, and Trade (MEDJCT): Ontario Research Fund - Research Excellence Round 10 (ORF-RE). The ORF-RE program provides funding to support the operational costs of major projects of strategic value to the province. This program provides up to one third of the total value of a project, with the remaining two thirds coming from private sector partners and institutional contributions. ORF-RE Round 10 has two application funding tiers: Tier 1 funds projects from $200,000 to $1,000,000. Open to all disciplines; Tier 2 funds projects from $1,000,001 to $4,000,000. Open to all disciplines. Further details, program guidelines and the application form will be available shortly.  Visit here for further details and timelines.
    INFORMATION SESSION: June 18, 2019 from 10am - 12pm in the Medical Sciences Building, Room 2173, 1 King's College Circle. RSVP to renee.leroux@utoronto.ca
    BUDGET INFORMATION SESSION: July 23, 2019 from 10am - 12pm in the Medical Sciences Building, Room 2173, 1 King's College Circle. RSVP to renee.leroux@utoronto.ca
     
  • Symposium - UofT Talks: Destination Health: Unpacking the Migrant Experience. This year's talk will be an evening of discourse on the barriers that migrants face in Canada when trying to access healthcare. As Canada accepts more and more refugees, it’s becoming increasingly important that we understand how this influx of people will impact an already stressed system. figure out how we can create supports to ensure that everyone that needs healthcare has access to it. Full agenda here.
    Date: June 20, 2019 from 6pm - 9pm at the Innis Town Hall Theatre, 2 Sussex Ave., Toronto
    Tickets@uofttalks.ca $15.00 general admission; $10 Student
     
  • CIHR and Muscular Dystrophy Canada (MDC): Network Catalyst Grants. This funding opportunity will provide support for the creation of six networks. The aim of these networks will be to provide research leadership in its focus area, to foster innovative research and practices, to build capacity and provide a forum that engages the research community and its partners (including but not limited to industry, charities, and patients and their carers). This opportunity will provide funding for networks in the priority research areas of the funding partners. For CIHR-IMHA and MDC, these areas include Musculoskeletal (MSK) Rehabilitation, Muscular Dystrophy and Skin Health. For CIHR-INMHA, these networks seek to catalyze new research areas within the Institute's mandate. Registration deadline: July 9, 2019; Full application deadline: August 8, 2019.
     
  • Lung Cancer Canada: Geoff Ogram Memorial Research Grant. This grant supports advancement in lung cancer research programs that are anywhere in the continuum from basic, high impact discovery to translational work of direct relevance to the clinic and beyond. The goal of the GOMRF program is to provide a mechanism for scientists to study innovations and accelerate the application of new knowledge relating to the early detection of lung cancer and the etiology of lung cancer in different demographics and populations. Applications are encouraged from, but not limited to, the areas of biomedical, clinical, health services, social, and population health research. One $25,000 grant will be awarded. The application form can be found hereDeadline for applications: June 28, 2019.
     
  • Simons Foundation Autism Research Initiative (SFARI): Bridge to Independence (BTI) Award. The BTI Award program promotes talented early-career scientists by facilitating their transition to research independence and providing grant funding at the start of their professorships. Annual Request for applications (RFA) open each spring and are aimed at senior postdoctoral fellows who intend to seek tenure-track faculty positions during the upcoming academic year. Awardees will receive a commitment of $495,000 over three years, activated upon assumption of a tenure-track professorship at a U.S. or Canadian research institution. Importantly, although eligible applicants must be currently in a postdoctoral training position, the BTI Award itself is not a training fellowship but a research grant to newly appointed faculty. Deadline for Letters of Intent and Letters of Recommendation: August 8, 2019.
     
  • Alex's Lemonade Stand Foundation.
    • 2019 Psychosocial Launch Grants are designed for early career researchers within 7 years of receiving their terminal degree/completing formal training. Funding will support studies that aim to explain and/or improve psychosocial outcomes of those affected by childhood cancer. Demonstration of outstanding mentorship and a career plan that shows commitment to pediatric cancer investigation are important components of a successful application. Maximum USD $50,000 per year for two years. Deadline for Letters of Intent: June 17, 2019.
    • 2019 Psychosocial Family Impact Grant is designed for established investigators. Funding will support studies that aim to explain and/or improve psychosocial outcomes of those affected by childhood cancer. This grant is designed to fund researchers who have novel approaches to understanding the psychosocial aspects of pediatric cancer and whose proposals will have clinically significant impact. Amount: Up to USD $100,000 per year for 3 years. Deadline for Letters of Intent: June 17, 2019.
       
  • Solving Kid's Cancer (SKC): Therapeutic Development Initiative (TDI) - Funding for High-Impact Pediatric Cancer Research. The TDI of SKC only supports clinical research. The organization specifically focuses on novel clinical studies for neuroblastoma, brain tumors and sarcomas. TDI Awards are funded in a range from USD $50,000 to USD $600,000 depending on the nature of the proposed project. No institutional overhead or indirect funding will be provided. Deadline for preliminary proposals: Continuous.
     
  • American Society of Clinical Oncology: Global Oncology Young Investigator Award (GO YIA). The GO YIA provides research funding to early-career investigators to encourage and promote quality research in global oncology and to develop the next generation researchers to address global health needs. "Global oncology" is a term that generally refers to the application of the concepts of global health to cancer, and implies an approach to the practice of oncology that acknowledges the reality of limited resources in most parts of the world. Amount: Up to USD $50,000 for one year. Deadline for applications: June 27, 2019.
     
  • National Organization for Rare Diseases (NORD): Rare Disease Research Grant Program. NORD’s Rare Disease Research Grant Program is accepting proposals for the study of the following eight rare diseases. All U.S. and international researchers interested in studying one or more of these diseases are encouraged to apply by Tuesday, June 18, 2019.
    • Alveolar Capillary Dysplasia with Misalignment of the Pulmonary Veins (ACD/MPV) – One grant of up to USD $50,000
    • Appendix Cancer and Pseudomyxoma Peritonei (PMP) – Two grants of up to a combined total of USD $100,000
    • Autoimmune Polyglandular Syndrome Type 1 (APS-1) – One grant of up to USD $100,000
    • Biliary Atresia – Two grants of up to a combined total of USD $190,500
    • Malonic Aciduria- One grant of up to USD $52,000
    • Neuroendocrine Cell Hyperplasia of Infancy (NEHI) – One grant of up to USD $30,000
    • New-Onset Refractory Status Epilepticus (NORSE) and Febrile Infection-Related Epilepsy Syndrome (FIRES) – Two grants of up to a combined total of USD $100,000
    • Primary Orthostatic Tremor – One grant of up to $42,500  
       
  • JDRF: Strategic Research Agreements - Multi-Project SRA. The JDRF SRA for multiple projects provides a mechanism to stimulate new collaborations between clinical and basic scientists and/or between scientists from diverse backgrounds as a means to conceive and develop new approaches to major challenges, potential breakthroughs, or persistent obstacles to progress along the various paths to prevent, treat or cure Type 1 diabetes and its complications. Available funding for the Strategic Research Agreement will be reviewed on a per-application basis. Deadline for concept papers/proposals: August 1, 2019; November 4, 2019; or February 3, 2020.
     
  • John Templeton Foundation: Small & Large Grants. Core Funding Areas: 1. Science & the Big Questions (Mathematical & Physical Sciences; Human Sciences; Philosophy & Theology); Public Engagement); 2. Character Virtue Development; 3. Individual Freedom & Free Markets; 4. Exceptional Cognitive Talent & Genius; 5. Genetics; and 6. Voluntary Family Planning. Individual grants range greatly in amount, from several thousand dollars to several million. Small Grants: USD $234,800 or less. Large Grants: more than USD $234,800. Grant duration is normally up to three years. Deadline for Letters of Inquiry/preliminary inquiry: August 16, 2019; Deadline for full proposals: January 17, 2020.
     
  • Epilepsy Foundation: New Therapy Commercialization Grant and Epilepsy Seal of Innovation Award. The Program seeks to advance the development of new therapies including but not limited to medicines, biologics or devices. All proposals must demonstrate a clear path from the lab to the patient and are evaluated with consideration for their potential value to patients, likelihood of successful development including regulatory approval and the timeframe of development. The Program also encourages 1:1 matching grants to academic and commercial entities to support the commercialization of novel approaches to the treatment of epilepsy. Amount: New Commercialization Grant - Up to USD $350,000 for up to two years; Epilepsy Seal of Innovation Award - Up to USD $200,000 for one year. Deadline for Letters of Intent: June 21, 2019 or January 28, 2020.
     
  • A-T Children's Project. Research Grant Program. Their greatest interest is in funding translational and clinical research projects, particularly those projects focused on the neurological problems faced by all patients with A-T. Amount: Up to USD $150,000 for up to two years. Deadline for Letters of Intent: August 1, 2019; Full application due: September 1, 2019.
     
  • Restless Legs Syndrome (RLS) Foundation: Research Grants. The RLS Foundation Research Grant Program supports basic and clinical restless legs syndrome (RLS) research. The Foundation challenges the research community to generate novel ideas to unlock the mysteries that will ultimately lead to a cure for this often devastating disease. Amount: USD $35,000 for one year. Deadline for proposals: Continuous.

May 31, 2019
 

  • NSERC's New "Alliance" Grant: INFORMATION SESSION. Presented by NSERC and hosted  by UofT's Innovations & Partnerships Office. NSERC is currently launching the new “Alliance” Grant – the Research Partnerships Program consolidating and replacing the previous suite of programs including Engage, Collaborative Research and Development (CRD), Industrial Research Chair (IRC), Strategic Partnerships programs (SPG-P and SPG-N), among others.  NSERC is currently accepting applications for large Alliance proposals only (in excess of $150K/yr NSERC support), and will shortly expand intake to include applications for lesser amounts, analogous to the majority of the previous programs.  All applications will be accepted on a rolling basis after the rollout is complete - there will be no application deadlines under Alliance. NSERC personnel will be presenting details of the Alliance program at an information session on the downtown St. George campus on the afternoon of June 26.  PIs and other interested members of the UofT community are welcome to attend.
    DATE: Wednesday, June 26 2019 at 1:30pm
    LOCATION: Bahen Centre (40 St. George), Rm 1170
     
  • The Centre for Aging + Brain Health Innovation (CABHI): Spark Program. CABHI is inviting point-of-care staff to accelerate their ideas into innovations that can improve the lives of older adults, persons with dementia and their care partners. The Spark program provides up to $50,000 (CAD) in project funding over 12 months that can be used to develop and refine early stage solutions or to adapt and test a commercially available solution in a seniors' care environment. Deadline for applications: July 5, 2019.
     
  • CIHR Collaborative Health Research Program (CHRP): Applicant WEBINAR. CIHR will be hosting the following webinar to support participants with the requirements of the funding opportunity “Operating Grant: Collaborative Health Research Projects (NSERC Partnered) (2019-2020)” and to answer questions on how to apply. 
    DATE: Monday, June 3, 2019 at 1:00pm ET
    Register here.
     
  • PRE-ANNOUNCEMENT: CIHR UK-Canada Diabetes Research Team Grants. The objective of this funding opportunity is to accelerate diabetes research into mechanisms and translational solutions to improve the lives of people with diabetes in Canada and the UK through research funding for internationally competitive and innovative UK-Canada Diabetes Research Teams that will enable the pursuit of shared research interests. The focus of the collaborative projects will be upon ‘mechanisms and translational solutions’. This is meant to focus on research applicable to UK and Canadian settings, not on global health. Launch: June 2019.
     
  • CIHR in partnership with Health Canada: SGBA+ Health Policy-Research Partnerships. In response to the Canadian government's renewed commitment to gender equality, in 2017 Health Canada approved a department-wide Sex and Gender Action Plan. A key activity within this action plan is a partnership between the CIHR Institute of Gender and Health (IGH), and Health Canada’s Gender and Health Unit (GHU). The aim of this collaboration is to fund Policy-Research Partnerships, which will help bridge the gaps between research knowledge and policy development, and support the rigorous application of SGBA+ to ensure Health Canada's outward facing activities address the diverse needs of women, men, girls, boys and gender-diverse people to maximize positive health outcomes and improve the health of Canadians. Research Areas: Applying a SGBA+ lens to prescription drug lifecycle management; and Applying a SGBA+ lens to medical device lifecycle management. Deadline for applications: September 10, 2019.
     
  • CIHR in partnership with the Terry Fox Research Institute: Terry Fox New Investigator Awards. This program will support outstanding New Investigators to collaborate, and be mentored by, one or more senior investigators of a currently funded research team. Specifically, the research teams are: Terry Fox New Frontiers Program Project; TFRI Translational Program; CIHR Cancer Control Partnerships in Health Services Improvement (PHSI) Grants; CIHR Stand Up to Cancer (SU2C) Canada Dream Teams; and CIHR Large Scale Applied Research Cancer Projects (LSARP).  The maximum amount per grant is $150,000 per year for up to 3 years for a total of $450,000. Deadline for applications: September 13, 2019.
     
  • The Ministry of Economic Development, Job Creation, and Trade (MEDJCT): Ontario Research Fund - Research Excellence Round 10 (ORF-RE). The ORF-RE program provides funding to support the operational costs of major projects of strategic value to the province. This program provides up to one third of the total value of a project, with the remaining two thirds coming from private sector partners and institutional contributions. ORF-RE Round 10 has two application funding tiers: Tier 1 funds projects from $200,000 to $1,000,000. Open to all disciplines; Tier 2 funds projects from $1,000,001 to $4,000,000. Open to all disciplines. Further details, program guidelines and the application form will be available shortly. An information session will be held in mid-June, details to follow. Visit here for further details and timelines.
     
  • American Thoracic Society: ATS Foundation Partner Grants - ATS Foundation/Hermansky-Pudlak Syndrome Network Research Grant. The focus of this research grant is proposals that have a high likelihood to advance the understanding of Hermansky-Pudlak Syndrome-associated lung disease. One grant of up to USD $80,000 over two years is available. Deadline for Letters of Intent: June 17, 2019; Full proposals due September 20, 2019.
     
  • Amgen Inc. Competitive Grant Program in Bone Research. The program aims to improve quality of osteoporosis care and patient outcomes, related to osteoporosis screening, diagnosis, and adherence to therapy. Visit here for specific predefined areas of research eligible for a Competitive Grant Program in Bone Research award. Amount: Up to USD $150,000. Deadline for applications: June 28, 2019.
     
  • Alzheimer's Drug Discovery Foundation (ADDF): Accelerating Drug Discovery for Frontotemporal Degeneration. The ADDF and The Association for Frontotemporal Degeneration (AFTD) seek to accelerate and support innovative small molecule and biologic (antibodies, oligonucleotides, peptides, gene therapy) drug discovery programs for FTD through this request for proposals. Average Award $100,000 - $150,000. Deadline for Letters of Intent: July 12, 2019; Full proposals due: August 10, 2019.
     
  • Alzheimer's Research UK (ARUK): Target Validation Pathfinder Grant.  The Target Validation Pathfinder grant scheme (TVPG) is designed to support translational research that shows potential for an application to the Dementia Consortium or collaboration with the ARUK Drug Discovery Alliance, but would benefit from funding for preliminary, early-stage target validation work or feasibility studies to establish the viability of an approach. Amount: Up to GBP  £50,000 for one year. Deadline for applications: July 3, 2019 or November 1, 2019.
     
  • Kennedy's Disease Association: KDA Research Grants. The Kennedy's Disease Association (KDA) is planning to fund one or more research grants this fall to further the understanding of the pathological mechanisms of Kennedy's Disease. Applications from junior investigators and from senior post-doctoral fellows are encouraged. For independent investigators, grants will be funding up to USD $75,000. For postdoctoral fellows/senior trainees, grants will be funding for up to USD $50,000. Deadline for proposals: July 13, 2019.
     
  • Histiocytosis Association: Request for Proposals. Proposals for scientific research are accepted for studies into the causes, mechanisms, and improved means of treatment for histiocytic disorders. Proposals are evaluated on the basis of science, feasibility, and relevance. All proposals are expected to address one or more of the histiocytic disorders. Amount: Up to USD $50,000 for one year. Deadline for proposals: July 1, 2019.
     
  • USAID: Innovations in Malaria Vaccine Development (IMV). USAID is seeking to enhance our malaria vaccine investments through a collaborative design process. The goal of USAID's MVDP is to demonstrate the proof of concept of a vaccine to reduce morbidity and mortality due to malaria caused by infection with Plasmodium falciparum. Target malaria vaccine end characteristics will include at least 75% efficacy and evidence of affordability. USAID intends to support efforts towards vaccines that have the potential to directly protect recipients against disease caused by P. falciparum such as vaccines that target the pre-erythrocytic (sporozoite and liver stage) and erythrocytic stages of the life cycle. Deadline for applications: June 21, 2019.

 

May 16, 2019
 

  • CIHR/CAAIF/AZ Canada/AllerGen Emerging Researcher Awards in Allergic Asthma. The goal of this funding opportunity is to support Canadian Allergists, Clinical Immunologists, MD clinician scientists and basic scientists working in translational research to pursue academic research in allergic asthma. All research proposals received must be relevant to the area of allergic asthma. Amount: $100,000 per year for up to 2 years. Deadline for applications: August 16, 2019.
     
  • Eczema Society of Canada: Research Grant Program.  This program allows Canadian researchers, including clinicians, medical students, and fellows, the opportunity to apply for funding for eczema research and/or educational projects that work to improve the lives of Canadians living with eczema. Up to two grants will be awarded in 2019 with a maximum value of $25,000 per grant. Deadline for applications: September 1, 2019.
     
  • Pfizer, Inc.: Requests for Proposals.
    • 2019 Global Hemophilia 2019  ASPIRE.  Projects that will be considered for Pfizer support will focus on the following areas in Gene Therapy for Hemophilia A or B:  Basic Science of TFPI & Anti-TFPI Monoclonal Antibodies; Patients with MILD Hemophilia A or B. Amount: Up to USD $125,000/year for 1 to 2 years. Pfizer anticipates awarding up to 2 grants.  Deadline for proposals: August 31, 2019.
    • Transthyretin Amyloid Cardiomyopathy (ATTR-CM) Research Competitive Grant Program for Junior Investigators. Projects that will be considered for Pfizer support will further improve the understanding of the epidemiology, basic science and early diagnosis and treatment of ATTR-CM through research focused in the following areas: Epidemiologic evaluations for ATTR-CM; Approaches for the early identification and follow up of ATTR-CM patients: • Evaluation of patients with ATTR-CM presenting with a mixed phenotype; Mechanistic studies to advance the basic science of amyloid formation and deposition on the heart; Characteristics of ATTR-CM in post-organ transplant patients, including natural course of disease progression. Amount: Up to USD $75,000 per project. Pfizer anticipates awarding 4 to 5 grants. Deadline for proposals: June 15, 2019.